Skip to main content
AAN.com
Article
November 1, 1993

Risk factors for nursing home placement in advanced Parkinson's disease

November 1993 issue
43 (11) 2227

Abstract

We evaluated the risk factors for nursing home placement of patients with Parkinson's disease (PD) by matching 11 PD patients permanently admitted to nursing homes with two control PD patients remaining at home. Risk factors assessed were motor severity, presence of hallucinations/delusions, and presence of memory problems. The only statistically significant risk factor was the presence of hallucinations/delusions. Motor severity and the presence of memory problems did not have an impact on nursing home placement. There was no risk factor synergy for hallucinations, motor disability, and mental impairment. Since all patients in this series who entered nursing homes remained there permanently, these data suggest that vigorous efforts to control hallucinations may be warranted to prevent nursing home placement.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 43Number 11November 1993
Pages: 2227
PubMed: 8232934

Publication History

Published online: November 1, 1993
Published in print: November 1993

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Christopher G. Goetz, MD
Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL.
Glenn T. Stebbins, PhD
Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis, Journal of Comparative Effectiveness Research, 13, 1, (2024).https://doi.org/10.57264/cer-2023-0114
    Crossref
  2. Exploring the Spectrum of Visual Illusions and Other Minor Hallucinations in Patients with Parkinson’s Disease in Lithuania, Medicina, 60, 4, (606), (2024).https://doi.org/10.3390/medicina60040606
    Crossref
  3. Therapeutic singing-induced swallowing exercise for dysphagia in advanced-stage Parkinson’s disease, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1323703
    Crossref
  4. Cholinergic deficiency in Parkinson’s disease patients with visual hallucinations, Brain, 147, 10, (3370-3378), (2024).https://doi.org/10.1093/brain/awae186
    Crossref
  5. Real or imagined: We need a new scale for psychosis in Parkinson's disease, Parkinsonism & Related Disorders, 121, (106004), (2024).https://doi.org/10.1016/j.parkreldis.2024.106004
    Crossref
  6. Behandlung psychotischer Symptome bei der Parkinsonkrankheit, InFo Neurologie + Psychiatrie, 26, 4, (34-43), (2024).https://doi.org/10.1007/s15005-024-3936-5
    Crossref
  7. Examining Agreement in Psychotic Symptom Assessment: Insights from Parkinson's Disease Dementia Dyads, Movement Disorders Clinical Practice, (2024).https://doi.org/10.1002/mdc3.14225
    Crossref
  8. Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in rats, Frontiers in Neuroscience, 17, (2023).https://doi.org/10.3389/fnins.2023.1237726
    Crossref
  9. Combined multidisciplinary in/outpatient rehabilitation delays definite nursing home admission in advanced Parkinson’s disease patients, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1128891
    Crossref
  10. Risk of hospitalization in synucleinopathies and impact of psychosis, Frontiers in Aging Neuroscience, 15, (2023).https://doi.org/10.3389/fnagi.2023.1274821
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share